Synergistic effects of silver ions and metformin against enterococcus faecalis under high-glucose conditions in vitro
BMC Microbiology volume 21, Article number: 261 (2021)
This study aimed to evaluate the synergistic antibacterial activities of silver ions (Ag+) and metformin hydrochloride (Met) against Enterococcus faecalis (E. faecalis) under normal or high-glucose conditions.
The minimum inhibitory concentration, minimum bactericidal concentration, growth curves, and colony-forming units were used to evaluate the antibacterial effects of Ag+ and Met on planktonic E. faecalis in Brain Heart Infusion broth with or without additional glucose. The influences of Ag+ and Met on four weeks E. faecalis biofilm on human dentin slices was also tested. Cytotoxicity was tested on MC3T3-E1 osteoblastic cells using CCK-8 assays. The results indicated that E. faecalis showed higher resistance to drug treatment under high-glucose conditions. Ag+ (40 μg/mL) plus Met (3.2% or 6.4%) showed enhanced antibacterial activities against both planktonic E. faecalis and biofilm on dentin slices, with low cytotoxicity.
Met enhanced the bactericidal effects of Ag+ against both planktonic and biofilm E. faecalis under normal or high-glucose conditions with low cytotoxicity. Further molecular studies are needed to be conducted to understand the mechanisms underlying the synergistic activity between Met and Ag+.
Bacteria remaining in the root canal system after initial treatment is often responsible for endodontic treatment failure and refractory apical periodontitis (AP) . These bacteria can survive and proliferate in the treated root canal by feeding on tissue fluid rich in glycoprotein from the periapical area and then induce or maintain inflammation around the periapical tissue . Facultative anaerobic and gram-positive bacteria were reported to be the predominant flora in canals of treatment failure . Enterococcus faecalis is one of the most frequently identified  due to its ability to survive in harsh environments such as extreme alkaline and nutrient deficiency conditions [4, 5]. In addition, antibiotics have been abused in recent decades with more and more serious resistance developed by many bacteria, and E. faecalis has also been reported to exhibit antibiotic resistance .
Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia, accompanied by immune dysfunction. Hyperglycemia leads to the formation of glycation end products, increasing tissue-oxidative stress and upregulating inflammatory responses, and reduces tissue repair capacity . People with diabetes are particularly vulnerable to anaerobic bacteria or opportunistic infections because of limited collateral circulation . E. faecalis was reported to have a higher detection rate (33%) in the infected root canals of patients with diabetes than in healthy patients (19%) . Previous animal and human studies have suggested an association between AP and DM , manifested by a higher prevalence of AP, the larger size of the periapical lesions and bone destruction, delayed periapical healing, and a lower success rate of root canal therapy in patients with diabetes. Patients with long-term DM also showed a higher incidence of periradicular lesions than those with short-term DM . DM must be considered critical factor affecting treatment prognosis .
Poorly controlled glycemia was significantly associated with AP, while metformin hydrochloride (Met), a typical medicine for hypoglycemia treatment, was associated with a lower prevalence of AP . Recently, Wang et al.  reported that intracanal application of Met paste could reduce bone resorption associated with AP and promote bone defect healing. Local delivery of Met may be effective for controlling root canal infections. Met has been reported to be multifunctional as having anti-inflammation, anti-aging and anti-tumor properties [15,16,17]. Met has also shown antimicrobial properties against multiple pathogens, such as Staphylococcus aureus and Pseudomonas aeruginosa, and possess an adjuvant antimicrobial effect when combined with other antibiotics [18,19,20]; however, its effectiveness against E. faecalis remains unknown.
Ag+ is recognized as a broad-spectrum bactericidal metal ion widely used in medical applications; however, Ag+ has also been reported to cause discoloration, eye irritation, and allergic contact dermatitis . E. faecalis has been proven to develop resistance against Ag+, leading to the metal’s decreased antibacterial effectiveness . To solve these problems, Ag+ or nanoparticles has been used with other metal ions or chemicals to obtain a stronger synergistic antibacterial effect and lower cytotoxicity [23,24,25,26]. Despite this, the antibacterial ability of Ag+ against E. faecalis in diabetic environments, that is, high-glucose condition, remains unknown. In addition, whether there is a synergistic antibacterial effect against E. faecalis between Met and Ag+ under high-glucose conditions also remains unclear.
Based on these concerns, this study aimed to investigate the synergistic antibacterial effect of Met and Ag+ against E. faecalis under normal or high-glucose conditions in vitro. It was hypothesized that Ag+ plus Met would show a synergistic inhibitory effect on planktonic E. faecalis and biofilm on dentin slices either in normal or high glucose conditions.
MIC and MBC determination
The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) results of Met and AgNO3 with or without Met against E. faecalis in Brain Heart Infusion (BHI) broth with or without additional glucose were shown in Table 1. The MBC99 of Met was not detected at the tested concentrations. Under different concentrations of Met (3.2 and 6.4%), the MIC and MBC99 of AgNO3 decreased drastically.
Antibacterial effects against planktonic E. faecalis
After the test of MIC and MBC, dynamic growth curve tests and the colony-forming unit (CFU)-counting method were used to detect the antibacterial effects of Ag+ (40 μg/mL), Met (3.2 and 6.4%), and Ag++Met on planktonic E. faecalis in BHI or BHIG broth. 2% chlorhexidine (CHX) was used as a positive control in the CFU-counting test. The results of dynamic growth curves in Fig. 1 indicate that the optical density (OD) values in the Ag++Met group were significantly decreased (p < 0.0001) within 10 h. The CFU-counting tests (Fig. 2) showed that compared to Ag+ or Met alone, the Ag++Met groups showed significantly lower CFU counts (p < 0.05) and increased antibacterial efficiencies (Table 2). Despite this, compared with normal BHI broth, the antibacterial efficiency decreased when more glucose was added to the culture medium.
Antibacterial effects against E. faecalis biofilm on dentin slices
Four-week E. faecalis biofilm were cultured on human dentin slices, and their antibacterial effects were tested. The OD600 value measured within 10 h showed significantly decreased residual bacterial amount from the dentin slices in the Ag++Met and CHX groups (Fig. 3, P < 0.05) compared to the control group, even under the high glucose condition.
The cytotoxicity of Ag+ and Met was assessed on MC3T3-E1 cells in vitro. The results of the CCK-8 test (Fig. 4) showed that the 2% CHX group had a significantly decreased OD450 value (p < 0.0001) and an inhibitory effect on cell proliferation. Although the AM6.4 group showed a slight inhibitory effect, there was no significant difference when compared with the negative control group (p > 0.05). All other groups showed low cytotoxicity (p > 0.05).
This study mainly focused on the synergistic inhibitory effect of Ag+ and Met on E. faecalis. MIC and MBC test, dynamic growth curve test and CFU-counting method were used to determine the synergistic antimicrobial effect on planktonic E. faecalis. The concentrations of metformin were selected based on the MIC test of metformin and pilot studies. The selected concentrations of 3.2 and 6.4% were 1/4 MIC and 1/2 MIC of metformin respectively, which could be better present the synergistic effect with silver ions than other concentrations as indicated in our pilot studies. According to the results, the combination of Ag+ (1/4 MIC) and Met (1/4 or 1/2 MIC) significantly inhibited the growth of planktonic E. faecalis in either normal or high glucose conditions. However, as previously reported, biofilm was more resistant to antimicrobial agents and harsh environments than planktonic bacteria . Despite this, the application of Ag+ plus Met also showed strong synergistic inhibition effect on four-week E. faecalis biofilm on human dentin slices. Ag+ plus Met may be developed into a new effective and safe multifunctional antibacterial agent for root canal disinfection or other related medical areas under diabetic conditions.
Previous studies have demonstrated that high glucose media can promote E. faecalis biofilm formation [28, 29]. Another study suggested that when grown in the presence of glucose supplementation, the penetration of E. faecalis into dentinal tubules was deeper . Local high-level glucose in diabetics may provide more energy resources for bacteria to survive starvation stress (a common condition for bacteria in filled root canals). In addition, human serum, as a nutrition source, favors E. faecalis to bind to collagen and invade dentinal tubules .
As a hypoglycemic medicine for the treatment of DM, Met has also been reported to be multifunctional as having anti-aging, anti-inflammation, anti-bacterial and anti-tumor properties [15,16,17, 19]. However, the potential application against E. faecalis has rarely been studied. In this study, MBC99 of Met was not detected at the tested concentrations, indicating the weak sterilization effect of Met on E. faecalis. In contrast, CHX, a biguanide compound, is widely used as an endodontic irrigant and medicament with confirmed activities against gram-positive and gram-negative bacteria, but showed lower cell viability compared to other irrigant in cytotoxicity tests [32, 33]. The differences of the bactericidal properties between CHX and Met may be owing to the biguanide configuration and the length of its alkyl side chain .
The molecular mechanism behind the antibacterial activity of Ag+ is thought to be the interaction between Ag+ and the bacterial cell envelope, DNA, enzymes and proteins (especially those with sulfhydryl groups) inside the cell, as well as the production of reactive oxygen species [35, 36]. Despite this, bacteria can develop resistance to Ag+ through various mechanisms such as the active efflux of ions from the cell . The intrinsic efflux system of E. faecalis was also reported to be controlled by the energy derived from the catabolism of glucose and the proton concentration of the medium . Proton motive force (PMF) is critical for membrane depolarization and the functions of the efflux pump, and the PMF can also be enhanced by glucose . The antibacterial effect of Ag+ in high glucose environment could probably be influenced by the sufficient glucose as an energy source for the efflux system. Met disrupt the bacterial cytoplasmic membrane and undermine the function of the PMF-driven efflux pump, therefore to promote the intracellular accumulation of doxycycline and restore tetracyclines susceptibility to multidrug-resistant bacteria . Met could possibly enhance the intracellular accumulation of Ag+ by increasing the permeability of the cell membrane and undermining the functions of the efflux pump, upon which the antibacterial effect of Ag+ was strengthened when acted together with Met.
Damage in the periapical tissues can be caused directly by virulence factors and production (such as lipoteichoic acids and extracellular superoxide production) of E. faecalis, or indirectly mediated by the host response [39, 40]. The nucleotide-binding domain, leucine-rich-containing family, pyrin domaincontaining-3 (NLRP3) inflammasome contributes to periapical inflammation caused by E. faecalis, and lipoteichoic acids was reported to induce NLRP3 inflammasome expression by activating the nuclear factor-kappa B (NF-κB) signaling pathway . DM shows a higher susceptibility to anaerobic infection due to the severely hypoxic environment in inflamed lesions. DM can also influence periapical status by increasing cellular oxidant stress, inducing apoptosis of osteoblasts and inhibiting osteoblastic differentiation . Metformin targets the NLRP3 inflammasome, and its anti-inflammatory effects are related to the NF-κB pathway and tumor necrosis factor alpha related genes . In addition, studies have confirmed the therapeutic efficacy of intracanal Met medication for periapical lesions, such as suppressing inducible nitric oxide synthase (iNOS) and nitric oxide (NO) production and protecting osteoblasts against hypoxia-induced oxidative stress and apoptosis [43, 44]. Despite these functions, further molecular studies need to be conducted to understand the mechanism of the synergistic activity between Met and Ag+.
In conclusion, Ag++Met synergism showed strong antibacterial activity against both planktonic and biofilm E. faecalis in either normal or high-glucose conditions with low cytotoxicity.
Materials and methods
All procedures in this study were performed in accordance with relevant guidelines. E. faecalis ATCC 29212 (ATCC, Manassas, VA, USA) was used in this study and stored at −80 °C with 50% glycerol. For all experiments, bacteria were grown in Brain Heart Infusion (BHI, BD Biosciences, Bergen, New Jersey, USA) at 37 °C in an anaerobic incubator with 5% CO2 and 1% O2, and the E. faecalis bacterial density was standardized to the OD value of 1.0, using a spectrophotometer (UV-2401PC, Shimadzu Corporation, Japan) at a wavelength of 600 nm, corresponding to a cell density of 109 CFU/mL. The standard bacterial suspension was used in subsequent experiments. BHIG broth was prepared by adding 25 mM glucose to the BHI broth.
MIC and MBC determination
The MIC for AgNO3 and Met was determined using the microdilution method as previously described . Briefly, AgNO3 or Met were prepared with sterile distilled water, and 100 μL of the test solution was added to a 96-well microtiter plate. Another 100 μL E. faecalis bacterial suspension (106 CFU/mL) diluted in double-concentrated BHI or BHIG broth was transferred into each well. For AgNO3 or Met alone, the final concentrations ranged from 5 to 640 μg/mL or from 0.1 to 12.8%, respectively. For the AgNO3 + Met test, the concentration of Met remained unchanged (3.2% or 6.4%) with AgNO3 ranging from 5 to 640 μg/mL. the plates were incubated for 24 h at 37 °C in an anaerobic incubator with 5% CO2 and 1% O2 in the dark. A micro-plate reader (Power Wave XS2, BioTek Instruments, VT, USA) was used at 600 nm to evaluate cell growth. Each assay contained both experimental and negative controls (media only). The MIC was defined as the lowest concentration that inhibited E. faecalis growth after incubation, showing OD600 values closest to hose of the negative controls. For MBC experiments, 100 μL of solutions from wells without turbidity were cultured on BHI agar. At least three wells (MIC, MIC × 2 and MIC × 4) were tested. MBC99 was determined to be the concentration with at least 99% inhibition. The measurements were performed in triplicate.
Dynamic growth curve determination
The antimicrobial effect identified of Ag+ and Met solutions was identified according to previous studies . Briefly, fresh E. faecalis suspension was adjusted to 108 CFU/mL and incubated with AgNO3 solutions (40 μg/mL), Met solutions (3.2% or 6.4%) or their combinations in BHI and BHIG broth at 37 °C in an anaerobic incubator with 5% CO2 and 1% O2 in the dark. Aliquots were retrieved and optical density was measured at 600 nm every 2 h. The negative control was defined as the untreated E. faecalis. Each test was repeated six times.
Colony forming units (CFU)
The CFU counting method  was used to detect the antibacterial effects of Ag+ and Met. Briefly, 1 mL suspension (104 CFU/mL) of E. faecalis was incubated with different concentrations of AgNO3 and Met in BHI and BHIG broth for 24 h at 37 °C in an anaerobic incubator with 5% CO2 and 1% O2 in the dark. 2% CHX was used as a positive control because of its confirmed bactericidal effectiveness. After serial 10-fold dilution or no, 10 μL of bacterial sample from each group was retrieved and inoculated on BHI agar plates for a further 24 h. the CFU of E. faecalis was counted to evaluate the number of viable bacteria. The test was repeated six times for each group.
According to the results of the CFU counting test, the antibacterial efficiency (%) against E. faecalis was calculated as:
Antibacterial effects against E. faecalis biofilm on dentin slices
Extracted third molar teeth were collected under the approval (2017–11) of the Ethics Committee of the School and Hospital of Stomatology, Wuhan University and cut into dentin slices with a size of 4 mm (width) × 4 mm (length) × 1 mm (thickness). All slices were thoroughly cleaned by ultrasound using distilled water, 5.25% sodium hypochlorite and 17% ethylenediaminetetraacetic acid in sequence for 4 min each, with distilled water for 1 min as the final wash. Finally, they were autoclaved at 121 °C in distilled water for 20 min [26, 46].
For the antibacterial effect test, all dentin slices were evenly divided into two groups and soaked in 1 mL E. faecalis suspension (108CFU/mL) in BHI or BHIG broth at 37 °C in an anaerobic incubator with 5% CO2 and 1% O2 for four weeks [47, 48] Fresh BHI or BHIG broth was changed every 48 h. For each culture medium, dentin slices were washed with phosphate-buffered saline (PBS) and randomly divided into six groups (n = 6), and then embedded with AgNO3, Met, AgNO3-Met, and CHX gels for 7 days at 37 °C. Gels were prepared by mixing 0.15 g methylcellulose (Aladdin Industrial Corporation, Shanghai, China) with 2 mL of tested solutions. After 7 days, the slices were gently washed with PBS for three times and then soaked in 2 mL of fresh BHI or BHIG broth. Biofilm cells were dispersed by vortex mixing for 1 min. During 10 h of incubation, 200 μL suspension was retrieved for absorbance measurement at 600 nm every 2 h. Dentin slices without medication (methylcellulose gel only) were set as the negative control, while the group treated with 2%CHX gel was set as the positive control.
The cytotoxicity of Ag+ and Met on MC3T3-E1 subclone 14 osteoblastic cells (ATCC CRL-2594) in vitro was assessed using the cell counting kit-8 (CCK-8, Dojindo Laboratories, Kumamato, Japan) according to the previous studies . Two hundred microliters of MC3T3-E1 cells (1 × 104 cells) were seeded into each well of a 96-well plate and cultured at 37 °C in a 5% CO2 atmosphere in α-minimum essential medium (α-MEM; Hyclone, Logan, UT, USA) with 10% fetal bovine serum (Hyclone) and 1% penicillin/streptomycin (Hyclone). The tested solutions were sterilized using a 0.22-μm filter (Merck Millipore Ltd., Darmstadt, Germany). After incubation for 24 h, the culture medium was replaced with 200 μL of α-MEM and 10 μL of different dilutions containing AgNO3(40 μg/ mL), Met (3.2% or 6.4%) or their combinations and CHX (2%). After incubating for another 24 h, the supernatant was removed and the plate was washed with PBS. Finally, 100 μL of fresh α-MEM and 10 μL of CCK-8 were added and incubated in the dark for 1 h. The supernatant was transferred to a new 96-well plate, and the absorbance at 450 nm was measured using a microplate reader. The untreated group was used as the control. Wells containing only CCK-8 and α-MEM were used for background recordings (BKG). Each group included six repeated wells.
All data are expressed as the mean ± S.E.M.. Data analysis was performed using the Graphpad Prism 8 (San Diego,CA). One-way analysis of variance (ANOVA) with a post hoc Dunnett t-test was performed for CFU and cytotoxicity assays. A two-way ANOVA was performed for the dynamic growth curve and biofilm assays. Statistical significance was set at P < 0.05.
Availability of data and materials
All data generated or analyzed during this study are included in this published article and its supplementary information files.
Siqueira JF, Rôças IN, Ricucci D, Hülsmann M. Causes and management of post-treatment apical periodontitis. Br Dent J. 2014;216:305–12.
Gomes BPFA, Pinheiro ET, Gadê-Neto CR, Sousa ELR, Ferraz CR, Zaia A, et al. Microbiological examination of infected dental root canals. Oral Microbiol Immunol. 2004;19:71–6.
Barbosa-Ribeiro M, Arruda-Vasconcelos R, Louzada LM, Dos Santos DG, Andreote FD, Gomes BPFA. Microbiological analysis of endodontically treated teeth with apical periodontitis before and after endodontic retreatment. Clin Oral Investig. 2021;25:2017–27.
Ran SJ, Jiang W, Zhu CL, Liang JP. Exploration of the mechanisms of biofilm formation by enterococcus faecalis in glucose starvation environments. Aust Dent J. 2015;60:143–53.
McHugh CP, Zhang P, Michalek S, Eleazer PD. pH required to kill enterococcus faecalis in vitro. J Endod. 2004;30:218–9.
Al-Ahmad A, Ameen H, Pelz K, Karygianni L, Wittmer A, Anderson AC, et al. Antibiotic resistance and capacity for biofilm formation of different bacteria isolated from endodontic infections associated with root-filled teeth. J Endod. 2014;40:223–30.
Arya S, Duhan J, Tewari S, Sangwan P, Ghalaut V, Aggarwal S. Healing of apical periodontitis after nonsurgical treatment in patients with type 2 diabetes. J Endod. 2017;43:1623–7.
Bender IB, Bender AB. Diabetes mellitus and the dental pulp. J Endod. 2003;29:383–9.
Fouad AF, Zerella J, Barry J, Spångberg LS. Molecular detection of enterococcus species in root canals of therapy-resistant endodontic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:112–8.
Pérez-Losada FL, Estrugo-Devesa A, Castellanos-Cosano L, Segura-Egea JJ, López-López J, Velasco-Ortega E. Apical periodontitis and diabetes mellitus type 2: a systematic review and meta-analysis. J Clin Med. 2020;9:540.
Mesgarani A, Haghanifar S, Eshkevari N, Ehsani M, Khafri S, Nafarzade S, et al. Frequency of odontogenic periradicular lesions in diabetic patients. Caspian J Intern Med. 2014;5:22–5.
Segura-Egea JJ, Cabanillas-Balsera D, Jiménez-Sánchez MC, Martín-González J. Endodontics and diabetes: association versus causation. Int Endod J. 2019;52:790–802.
Yip N, Liu C, Wu D, Fouad AF. The association of apical periodontitis and type 2 diabetes mellitus: a large hospital network cross-sectional case-controlled study. J Am Dent Assoc. 2021;152:434–43.
Wang HW, Lai EH, Yang CN, Lin SK, Hong CY, Yang H, et al. Intracanal metformin promotes healing of apical periodontitis via suppressing inducible nitric oxide synthase expression and monocyte recruitment. J Endod. 2020;46:65–73.
Cameron AR, Morrison VL, Levin D, Mohan M, Forteath C, Beall C, et al. Anti-inflammatory effects of metformin irrespective of diabetes status. Circ Res. 2016;119:652–65.
Soukas AA, Hao H, Wu L. Metformin as anti-aging therapy: is it for everyone? Trends Endocrinol Metab. 2019;30:745–55.
Chen GG, Woo P, Ng S, Wong G, Chan D, van Hasselt CA, et al. Impact of metformin on immunological markers: implication in its anti-tumor mechanism. Pharmacol Ther. 2020;213:107585.
Patkee WR, Carr G, Baker EH, Baines DL, Garnett JP. Metformin prevents the effects of Pseudomonas aeruginosa on airway epithelial tight junctions and restricts hyperglycaemia-induced bacterial growth. J Cell Mol Med. 2016;20:758–64.
Malik F, Mehdi SF, Ali H, Patel P, Basharat A, Kumar A, et al. Is metformin poised for a second career as an antimicrobial? Diabetes Metab Res Rev. 2018;34:e2975.
Liu Y, Jia Y, Yang K, Li R, Xiao X, Zhu K, et al. Metformin restores tetracyclines susceptibility against multidrug resistant bacteria. Adv Sci (Weinh). 2020;7:1902227.
Hadrup N, Sharma AK, Loeschner K. Toxicity of silver ions, metallic silver, and silver nanoparticle materials after in vivo dermal and mucosal surface exposure: a review. Regul Toxicol Pharmacol. 2018;98:257–67.
Cui J, Sun Q, Duan M, Liu D, Fan W. Establishment and characterization of silver-resistant enterococcus faecalis. Folia Microbiol. 2020;65:721–33.
Montelongo-Peralta LZ, Leon-Buitimea A, Palma-Nicolas JP, Gonzalez-Christen J, Morones-Ramirez JR. Antibacterial activity of combinatorial treatments composed of transition-metal/antibiotics against mycobacterium tuberculosis. Sci Rep. 2019;9:5471.
Katva S, Das S, Moti HS, Jyoti A, Kaushik S. Antibacterial synergy of silver nanoparticles with gentamicin and chloramphenicol against enterococcus faecalis. Pharmacogn Mag. 2018;13:S828–33.
Fan W, Duan M, Sun Q, Fan B. Simvastatin enhanced antimicrobial effect of Ag+ against E. Faecalis infection of dentine through PLGA co-delivery submicron particles. J Biomater Sci Polym Ed. 2020;31:2331–46.
Fan W, Sun Q, Li Y, Tay FR, Fan B. Synergistic mechanism of Ag+–Zn2+ in anti-bacterial activity against enterococcus faecalis and its application against dentin infection. J Nanobiotechnology. 2018;16:10.
Bowler P, Murphy C, Wolcott R. Biofilm exacerbates antibiotic resistance: is this a current oversight in antimicrobial stewardship? Antimicrob Resist Infect Control. 2020;9:162.
Pillai SK, Sakoulas G, Eliopoulos GM, Moellering RC, Murray BE, Inouye RT. Effects of glucose on fsr-mediated biofilm formation in enterococcus faecalis. J Infect Dis. 2004;190:967–70.
Seneviratne CJ, Yip JWY, Chang JWW, Zhang CF, Samaranayake LP. Effect of culture media and nutrients on biofilm growth kinetics of laboratory and clinical strains of enterococcus faecalis. Arch Oral Biol. 2013;58:1327–34.
George S, Kishen A, Song KP. The role of environmental changes on monospecies biofilm formation on root canal wall by enterococcus faecalis. J Endod. 2005;31:867–72.
Love RM. Enterococcus faecalis--a mechanism for its role in endodontic failure. Int Endod J. 2001;34:399–405.
Mohammadi Z, Abbott PV. The properties and applications of chlorhexidine in endodontics. Int Endod J. 2009;42:288–302.
Basrani B, Tjäderhane L, Santos JM, Pascon E, Grad H, Lawrence HP, et al. Efficacy of chlorhexidine- and calcium hydroxide–containing medicaments against enterococcus faecalis in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:618–24.
Tanzer JM, Slee AM, Kamay BA. Structural requirements of guanide, biguanide, and bisbiguanide agents for antiplaque activity. Antimicrob Agents Chemother. 1977;12:721–9.
Mijnendonckx K, Leys N, Mahillon J, Silver S, Van Houdt R. Antimicrobial silver: uses, toxicity and potential for resistance. Biometals. 2013;26:609–21.
Kędziora A, Speruda M, Krzyżewska E, Rybka J, Łukowiak A, Bugla-Płoskońska G. Similarities and differences between silver ions and silver in nanoforms as antibacterial agents. Int J Mol Sci. 2018;19:444.
Spengler G, Martins A, Schelz Z, Rodrigues L, Aagaard L, Martins M, et al. Characterization of intrinsic efflux activity of enterococcus faecalis ATCC29212 by a semi-automated ethidium bromide method. In Vivo. 2009;23:81–7.
Li XZ, Nikaido H, Williams KE. Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins. J Bacteriol. 1997;179:6127–32.
Kayaoglu G, Ørstavik D. Virulence factors of enterococcus faecalis: relationship to endodontic disease. Crit Rev Oral Biol Med. 2004;15:308–20.
Graunaite I, Lodiene G, Maciulskiene V. Pathogenesis of apical periodontitis: a literature review. J Oral Maxillofac Res. 2012;2:e1.
Wang L, Jin H, Ye D, Wang J, Ao X, Dong M, et al. Enterococcus faecalis lipoteichoic acid–induced NLRP3 inflammasome via the activation of the nuclear factor kappa B pathway. J Endod. 2016;42:1093–100.
Segura-Egea JJ, Martín-González J, Castellanos-Cosano L. Endodontic medicine: connections between apical periodontitis and systemic diseases. Int Endod J. 2015;48:933–51.
Tan Y, Chen J, Jiang Y, Chen X, Li J, Chen B, et al. The anti-periodontitis action of metformin via targeting NLRP3 inflammasome. Arch Oral Biol. 2020;114:104692.
Lai EH, Yang CN, Lin SK, Wang HW, Kok SH, Hong CY, et al. Metformin ameliorates periapical lesions through suppression of hypoxia-induced apoptosis of osteoblasts. J Endod. 2018;44:1817–25.
Sun M, Dong J, Xia Y, Shu R. Antibacterial activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against planktonic and biofilm growing Streptococcus mutans. Microb Pathog. 2017;107:212–8.
Yuan L, Lyu P, Huang YY, Du N, Qi W, Hamblin MR, et al. Potassium iodide enhances the photobactericidal effect of methylene blue on enterococcus faecalis as planktonic cells and as biofilm infection in teeth. J Photochem Photobiol B. 2020;203:111730.
Swimberghe R, Coenye T, De Moor R, Meire MA. Biofilm model systems for root canal disinfection: a literature review. Int Endod J. 2019;52:604–28.
Wu D, Fan W, Kishen A, Gutmann JL, Fan B. Evaluation of the antibacterial efficacy of silver nanoparticles against enterococcus faecalis biofilm. J Endod. 2014;40:285–90.
Murakami Y, Kawata A, Suzuki S, Fujisawa S. Cytotoxicity and pro−/anti-inflammatory properties of cinnamates, acrylates and methacrylates against raw264.7 cells. In Vivo. 2018;32:1309–22.
This study was financially supported by the National Natural Science Foundation of China (Grant No. 81570969&81771067) and the Top Youth Talent in Medicine Program of Hubei Province, China.
Ethics approval and consent to participate
Dentin slices were prepared from extracted third molar teeth collected under the approval (2017–11) of the Ethics Committee of School and Hospital of Stomatology, Wuhan University, and written informed consent was obtained from the participants for collection of third molar teeth. All procedures in this study were performed in accordance with relevant guidelines.
Consent for publication
All authors read and approved the final manuscript.
All authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Data of dynamic growth curve test were shown as mean OD600 and Standard Error of Means (SEM), which was plotted in Fig. 1. Table S2. Data of colony-forming units (CFU)-counting test were shown as mean counting and SEM, which was plotted in Fig. 2. Table S3. Data of biofilm test on dentin slices were shown as mean OD600 and SEM, which was plotted in Fig. 3. Table S4. Data of cytotoxicity assays were shown as mean OD450 and SEM, which was plotted in Fig. 4.
About this article
Cite this article
Wu, X., Fan, W. & Fan, B. Synergistic effects of silver ions and metformin against enterococcus faecalis under high-glucose conditions in vitro. BMC Microbiol 21, 261 (2021). https://doi.org/10.1186/s12866-021-02291-2
- Enterococcus faecalis
- Silver ion